HIGHLIGHTS
- who: Tanapati Phakham from the Chulalongkorn University Bangkok, Thailand have published the research: Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development, in the Journal: Scientific Reports Scientific Reports
- what: The authors demonstrated a highly efficient strategy for generating, screening, and characterizing chimeric anti-PD-1 antibodies; see the workflow in Fig 1. This study shows the details of the hybridoma generation, selection, and screening procedure to successfully develop high-potency chimeric anti-PD-1 mAbs for cancer immunotherapy. Collectively, although each of the technique employed for the hybridoma generation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.